By Shania Kennedy
May 03, 2024 – A team of researchers from Cleveland Clinic found that machine learning can help characterize how gut microbial metabolites and cell receptors interact to influence Alzheimer’s disease, according to a…
Continue Reading
Deep learning approaches for clinical predictions based on magnetic resonance imaging data have shown great promise as a translational technology for diagnosis and prognosis in neurological disorders, but its clinical impact has been limited….
Continue Reading
Worcestershire Acute Hospitals NHS Trust has implemented new artificial intelligence software that is helping to save the lives of stroke patients by analysing brain images. The RapidAI software analyses brain images to help clinicians…
Continue Reading
The South Korean Ministry of Food and Drug Safety (MFDS) has recently approved two digital devices that assist in respiratory rehabilitation and treatment of vision impairment due to cognitive illnesses.EasyBreath by Share & Service…
Continue Reading
Dr. Peter Bonutti, M.D., a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience again joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric…
NeuroX, a neurology-focused online consultation service, and its physician network ATP Partners announced it will participate in the Centers for Medicare and Medicaid Services (CMS) GUIDE Program to enhance care for dementia patients. NeuroX, American…
Continue Reading
NTT DATA has unveiled two new solutions designed to support elderly people living with dementia that use the power of artificial intelligence.Its first solution is the Brain Bio-Digital Twin project, an initiative that creates…
Continue Reading
Purchase Expands Linus Health’s Cognitive Assessment Capabilities
Linus Health, a digital health company enabling early detection of Alzheimer’s and other dementias, today announced it has acquired Aural Analytics, a leader in clinical-grade speech analytics. The…
What You Should Know:
myTomorrows, a global health technology company connecting patients with all possible treatment options, today announced a new partnership with brainstrust, a UK-based charity that helps people living with a brain tumor…
Continue Reading
Otsuka Pharmaceuticals and Click Therapeutics announced that Rejoyn, a smartphone-based prescription digital therapeutic for major depressive disorder (MDD), scored FDA clearance to be used as an adjunct to clinician-managed care. Rejoyn is a six-week remote…
Continue Reading
